title: Toward illness phase-specific pharmacotherapy for schizophrenia.
authors.affiliation: Departments of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Department of Neurobiology, Yale University School of Medicinem, New Haven, Connecticut; Yale-New Haven Hospital, New Haven, Connecticut. Electronic address: john.krystal@yale.edu.
authors.forename: John H
authors.initials: JH
authors.lastname: Krystal
authors.affiliation: Departments of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Department of Psychology, Yale University School of Medicine; New Haven, Connecticut; Abraham Ribicoff Research Facilities, Connecticut Mental Health, New Haven, Connecticut.
authors.forename: Alan
authors.initials: A
authors.lastname: Anticevic
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000627:therapeutic use*; D003499:Cyclic S-Oxides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018094:Receptors, Metabotropic Glutamate / Q000819:agonists*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D003499:Cyclic S-Oxides; D018094:Receptors, Metabotropic Glutamate